Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia von Stein, Eytan M., DiNardo, Courtney D., Pollyea, Daniel A., Fathi, Amir T., Roboz, Gail J., Altman, Jessica K., Stone, Richard M., DeAngelo, Daniel J., Levine, Ross L., Flinn, Ian W., Kantarjian, Hagop M., Collins, Robert, Patel, Manish R., Frankel, Arthur E., Stein, Anthony, Sekeres, Mikkael A., Swords, Ronan T., Medeiros, Bruno C., Willekens, Christophe, Vyas, Paresh, Tosolini, Alessandra, Xu, Qiang, Knight, Robert D., Yen, Katharine E., Agresta, Sam, de Botton, Stephane, Tallman, Martin S.

Volltext

Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society Statement von Rivera, M Patricia, Katki, Hormuzd A, Tanner, Nichole T, Triplette, Matthew, Sakoda, Lori C, Wiener, Renda Soylemez, Cardarelli, Roberto, Carter-Harris, Lisa, Crothers, Kristina, Fathi, Joelle T, Ford, Marvella E, Smith, Robert, Winn, Robert A, Wisnivesky, Juan P, Henderson, Louise M, Aldrich, Melinda C

Volltext

The role of FLT3 inhibitors in the treatment of FLT3‐mutated acute myeloid leukemia von Fathi, Amir T., Chen, Yi‐Bin

Volltext

Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark von Taylor, Justin, Haddadin, Michael, Upadhyay, Vivek A., Grussie, Erwin, Mehta-Shah, Neha, Brunner, Andrew M., Louissaint, Abner, Lovitch, Scott B., Dogan, Ahmet, Fathi, Amir T., Stone, Richard M., Tallman, Martin S., Rampal, Raajit K., Neuberg, Donna S., Stevenson, Kristen E., Horwitz, Steven M., Lane, Andrew A.

Volltext

Emergence of crenolanib for FLT3-mutant AML von Fathi, Amir T.

Volltext

Cucurbitacins inspired organic synthesis: Potential dual inhibitors targeting EGFR – MAPK pathway von Mahnashi, Mater, Elgazwi, Sara M., Ahmed, Mahmoud Salama, Halaweish, Fathi T.

Volltext

The evolving role of FLT3 inhibitors in acute myeloid leukemia: quizartinib and beyond von Wander, Seth A., Levis, Mark J., Fathi, Amir T.

Volltext

In vitro and QSAR studies of cucurbitacins on HepG2 and HSC-T6 liver cell lines von Bartalis, Judit, Halaweish, Fathi T.

Volltext

Cucurbitacin D exhibits potent anti-cancer activity in cervical cancer von Sikander, Mohammed, Hafeez, Bilal Bin, Malik, Shabnam, Alsayari, Abdulrhman, Halaweish, Fathi T., Yallapu, Murali M., Chauhan, Subhash C., Jaggi, Meena

Volltext

Bone marrow response as a potential biomarker of outcomes in glioblastoma patients von Vaios, Eugene J, Nahed, Brian V, Muzikansky, Alona, Fathi, Amir T, Dietrich, Jorg

Volltext

Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML von Perl, Alexander E, Martinelli, Giovanni, Cortes, Jorge E, Neubauer, Andreas, Berman, Ellin, Paolini, Stefania, Montesinos, Pau, Baer, Maria R, Larson, Richard A, Ustun, Celalettin, Fabbiano, Francesco, Erba, Harry P, Di Stasi, Antonio, Stuart, Robert, Olin, Rebecca, Kasner, Margaret, Ciceri, Fabio, Chou, Wen-Chien, Podoltsev, Nikolai, Recher, Christian, Yokoyama, Hisayuki, Hosono, Naoko, Yoon, Sung-Soo, Lee, Je-Hwan, Pardee, Timothy, Fathi, Amir T, Liu, Chaofeng, Hasabou, Nahla, Liu, Xuan, Bahceci, Erkut, Levis, Mark J

Volltext

Nanoparticle formulation of ormeloxifene for pancreatic cancer von Khan, Sheema, Chauhan, Neeraj, Yallapu, Murali M, Ebeling, Mara C, Balakrishna, Swathi, Ellis, Robert T, Thompson, Paul A, Balabathula, Pavan, Behrman, Stephen W, Zafar, Nadeem, Singh, Man M, Halaweish, Fathi T, Jaggi, Meena, Chauhan, Subhash C

Volltext

Novel series of 6-(2-substitutedacetamido)-4-anilinoquinazolines as EGFR-ERK signal transduction inhibitors in MCF-7 breast cancer cells von Ismail, Rania S.M., Abou-Seri, Sahar M., Eldehna, Wagdy M., Ismail, Nasser S.M., Elgazwi, Sara M., Ghabbour, Hazem A., Ahmed, Mahmoud Salama, Halaweish, Fathi T., Abou El Ella, Dalal A.

Volltext

Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response von Fathi, Amir T., Sadrzadeh, Hossein, Borger, Darrell R., Ballen, Karen K., Amrein, Philip C., Attar, Eyal C., Foster, Julia, Burke, Meghan, Lopez, Hector U., Matulis, Christina R., Edmonds, Katherine M., Iafrate, A. John, Straley, Kimberly S., Yen, Katharine E., Agresta, Samuel, Schenkein, David P., Hill, Cedric, Emadi, Ashkan, Neuberg, Donna S., Stone, Richard M., Chen, Yi-Bin

Volltext

FLT3 Inhibition as Therapy in Acute Myeloid Leukemia: A Record of Trials and Tribulations von Fathi, Amir T., Chabner, Bruce A.

Volltext

A New Dancing Partner for Venetoclax: Gilteritinib von Fathi, Amir T

Volltext

Cucurbitacins: potential candidates targeting mitogen-activated protein kinase pathway for treatment of melanoma von Ahmed, Mahmoud S., Halaweish, Fathi T.

Volltext

Design, synthesis, and biological evaluation of steroidal analogs as estrogenic/anti-estrogenic agents von Alsayari, Abdulrhman, Kopel, Lucas, Ahmed, Mahmoud Salama, Pay, Adam, Carlson, Taylor, Halaweish, Fathi T.

Volltext

Sofosbuvir Thio-analogues: Synthesis and Antiviral Evaluation of the First Novel Pyridine- and Pyrimidine-Based Thioglycoside Phosphoramidates von Abu-Zaied, Mamdouh Attia, Hammad, Sherif F, Halaweish, Fathi T, Elgemeie, Galal Hamza

Volltext

The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort von Stahl, Maximilian, DeVeaux, Michelle, de Witte, Theo, Neukirchen, Judith, Sekeres, Mikkael A., Brunner, Andrew M., Roboz, Gail J., Steensma, David P., Bhatt, Vijaya R., Platzbecker, Uwe, Cluzeau, Thomas, Prata, Pedro H., Itzykson, Raphaël, Fenaux, Pierre, Fathi, Amir T., Smith, Alexandra, Germing, Ulrich, Ritchie, Ellen K., Verma, Vivek, Nazha, Aziz, Maciejewski, Jaroslaw P., Podoltsev, Nikolai A., Prebet, Thomas, Santini, Valeria, Gore, Steven D., Komrokji, Rami S., Zeidan, Amer M.

Volltext